David Thomson
Algemeen Adviseur bij MANNKIND CORPORATION
Vermogen: 4 M $ op 31-05-2024
Actieve functies van David Thomson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MANNKIND CORPORATION | Algemeen Adviseur | 01-01-2002 | - |
| Bedrijfssecretaris | 01-01-2002 | - | |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - | - |
Loopbaan van David Thomson
Opleiding van David Thomson
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Canada | 3 |
Operationeel
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Secretary | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Beurs
- Insiders
- David Thomson
- Ervaring
